Table 2 Summary of time-varying characteristics over all study visits

CRP, mg/dl

0.48 (1.48)

(0.01–12.60)

ESR, mm/h

15.14 (44.05)

(1–120)

Tender joint count

0.33 (0.92)

(0–6)

Swollen joint count

0.41 (1.19)

(0–8)

Patient’s global assessment, VAS, mm

7.73 (14.57)

(0–100)

DAS28-ESR

1.87 (0.91)

(0.00–4.75)

Health Assessment Questionnaire

0.25 (0.50)

(0.00–2.88)

Multi-biomarker disease activity

23.23 (10.75)

(13–49)

Dose percentage (ratio of the full dosage)

0.67 (0.29)

(0.00–1.00)

Relative week of visit (baseline visit is week 0)

23.81 (17.53)

(0–59)

BMI, kg/m²

25.19 (3.86)

(17.5–39.45)

Dose percentage change*

−0.06 (0.27)

(−1.0–1.00)

Previous flare indicator (year/n)

0.23 (0.42)

(0.00–1.00)